October 16, 2026

Abivax SA (ABVX) Stock Report: Strong Buy Ratings Signal 77% Potential Upside in Biotech Innovator

Abivax SA (ABVX), a Paris-based biotechnology firm specializing in therapeutics for chronic inflammatory diseases, is capturing investor attention with a compelling 77.08% potential upside, as indicated..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a 149% Potential Upside in Precision Medicine

For investors seeking opportunities in the healthcare sector, particularly within the burgeoning field of biotechnology, Tyra Biosciences, Inc. (NASDAQ: TYRA) presents a compelling case. As a..

Precigen, Inc. (PGEN) Stock Analysis: Unpacking the 89.72% Potential Upside for Biotech Investors

For those venturing into the world of biotechnology investments, Precigen, Inc. (NASDAQ: PGEN) presents an intriguing opportunity that combines cutting-edge gene and cell therapy innovations with..

Myriad Genetics (MYGN) Investor Outlook: Navigating Challenges in the Diagnostics & Research Sector

Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is catching investor attention with its innovative molecular diagnostic tests...

AbCellera Biologics Inc. (ABCL) Stock Analysis: Potential 32.64% Upside Attracts Investors Amid Challenging Metrics

AbCellera Biologics Inc. (NASDAQ: ABCL), a biotechnology firm based in Vancouver, Canada, is making waves in the healthcare sector with its focus on developing antibody-based medicines...

Cel-Sci Corporation (CVM): Analyst Ratings Signal a 618% Upside in Biotech Play

For investors keeping a keen eye on the biotechnology sector, Cel-Sci Corporation (NASDAQ: CVM) presents a fascinating opportunity. As a clinical-stage biotechnology firm, Cel-Sci is at..

REGENXBIO Inc. (RGNX) Stock Analysis: Unveiling a 229% Potential Upside in Biotech Investing

Investors with an appetite for high-risk, high-reward opportunities may find REGENXBIO Inc. (NASDAQ: RGNX) an intriguing prospect within the biotechnology sector. With a market capitalization of..

Claritev Corporation (CTEV) Stock Analysis: A 92.79% Potential Upside in the Healthcare Sector

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare sector, is drawing significant attention from investors due to its impressive potential upside of 92.79%. Despite..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a 3.47% Potential Upside

Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, is facing a challenging yet potentially rewarding landscape. With a market cap of..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Navigating Growth with a 20.61% Potential Upside

Investors seeking opportunities in the healthcare sector may find OrthoPediatrics Corp. (NASDAQ: KIDS) an intriguing prospect, particularly given its focus on the niche but critical market..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring Its Strategic Positioning Amidst Market Stagnation

Investors interested in the biotechnology sector may find Theravance Biopharma, Inc. (NASDAQ: TBPH) to be an intriguing subject due to its strategic collaborations and niche product..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 123.80% Upside Potential in Biotech

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical innovator, has been garnering significant attention within the biotechnology sector, largely due to its promising pipeline and the..

Autolus Therapeutics plc (AUTL) Stock Analysis: Exploring a 407% Potential Upside in Biotech

Autolus Therapeutics plc (AUTL) presents a compelling opportunity for investors eyeing the biotechnology sector, particularly those interested in innovative cancer therapies. With a market capitalization of..

Simulations Plus, Inc. (SLP) Stock Analysis: Is There Value in Stability with a $374 Million Market Cap?

Simulations Plus, Inc. (NASDAQ: SLP), a stalwart in the healthcare sector focusing on health information services, has long been a pivotal player in the development of..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Neuropace, Inc. (NPCE) Stock Analysis: Navigating a 56% Potential Upside with Healthcare Innovation

Investors eyeing the healthcare sector might want to take a closer look at Neuropace, Inc. (NASDAQ: NPCE), a promising player in the medical device industry. With..

Personalis, Inc. (PSNL) Investor Outlook: Navigating the Path with Strong Revenue Growth Amid Valuation Challenges

Personalis, Inc. (NASDAQ: PSNL), a rising entity in the healthcare sector, primarily operates within the diagnostics and research industry. Based in Fremont, California, this company has..

Orthofix Medical Inc. (OFIX) Stock Analysis: Assessing a 35% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the medical technology industry, has been garnering attention from investors, particularly in the healthcare sector. With a..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 69.48% Potential Upside Amid Strong Buy Ratings

For investors eyeing the biotechnology sector, Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) presents a compelling case with a remarkable potential upside of 69.48%, driven by its strategic..

LifeMD, Inc. (LFMD) Stock Analysis: Unpacking a 230% Potential Upside in the Telehealth Sector

LifeMD, Inc. (LFMD), a burgeoning player in the healthcare sector, is carving out a niche in the health information services industry with its innovative direct-to-patient telehealth..

Search

Funds

October 16, 2026

Search

Funds

October 16, 2026

FTSE 100

Funds